Related Organization(s)

You just read:

DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists

News provided by

Institut de Cardiologie de Montréal

Jun 08, 2015, 08:00 ET